Page 1 | Search Results | Journal of Experimental Medicine

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment

In Special Collection:

Clinical Collection Spring 2019 , Scientific and Technical Advances in Cancer Immunology 2019

J Exp Med (2018) 215 (11): 2748–2759.

https://doi.org/10.1084/jem.20181003

Published: 26 September 2018

View articletitled, Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment

Includes: Supplementary data

Journal Articles

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

In Special Collection:

2018 Nobel Prize Collection

Xiaozhou Fan, Sergio A. Quezada, Manuel A. Sepulveda, Padmanee Sharma, James P. Allison

J Exp Med (2014) 211 (4): 715–725.

https://doi.org/10.1084/jem.20130590

Published: 31 March 2014

View articletitled, Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

Journal Articles

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz, Manuel A. Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y. Henry, Hideo Yagita, Jedd D. Wolchok, Karl S. Peggs, Jeffrey V. Ravetch, James P. Allison, Sergio A. Quezada

J Exp Med (2013) 210 (9): 1695–1710.

https://doi.org/10.1084/jem.20130579

Published: 29 July 2013

View articletitled, Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Journal Articles

Tumor-reactive CD4⁺ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

In Special Collection:

2018 Nobel Prize Collection

Sergio A. Quezada, Tyler R. Simpson, Karl S. Peggs, Taha Merghoub, Jelena Vider, Xiaozhou Fan, Ronald Blasberg, Hideo Yagita, Pawel Muranski, Paul A. Antony, Nicholas P. Restifo, James P. Allison

J Exp Med (2010) 207 (3): 637–650.

https://doi.org/10.1084/jem.20091918

Published: 15 February 2010

View articletitled, Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

Includes: Supplementary data

Journal Articles

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

In Special Collection:

2018 Nobel Prize Collection

Karl S. Peggs, Sergio A. Quezada, Cynthia A. Chambers, Alan J. Korman, James P. Allison

J Exp Med (2009) 206 (8): 1717–1725.

https://doi.org/10.1084/jem.20082492

Published: 06 July 2009

View articletitled, Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

Includes: Supplementary data

Journal Articles

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, Yuelei Shen, Dan R. Littman, James P. Allison

J Exp Med (2008) 205 (9): 2125–2138.

https://doi.org/10.1084/jem.20080099

Published: 25 August 2008

View articletitled, Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

Includes: Multimedia, Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Filters

Date

Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tumor-reactive CD4⁺ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

Email alerts

Update search

Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

Email alerts

This Feature Is Available To Subscribers Only

Tumor-reactive CD4⁺ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts